BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gallian P, Barlet V, Mouna L, Gross S, Morel P, Le Cam S, Ricard C, Maugard C, Pouchol E, Flan B, Visse C, Djoudi R, Figoni J, De Valk H, Tiberghien P, Roque-Afonso AM. Persisting higher prevalence of hepatitis A virus RNA in blood donors, France, 2018. Euro Surveill 2019;24. [PMID: 31771700 DOI: 10.2807/1560-7917.ES.2019.24.47.1900695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Severi E, Georgalis L, Pijnacker R, Veneti L, Turiac IA, Chiesa F, Rizzo C, Martinelli D, Vold L, Herrador BG, Martinez CV, Sanchez EVM, Semenza JC, Lopalco P, Dahlström LA, Giesecke J. Severity of the clinical presentation of hepatitis A in five European countries from 1995 to 2014. Int J Infect Dis 2022:S1201-9712(22)00058-3. [PMID: 35134558 DOI: 10.1016/j.ijid.2022.01.053] [Reference Citation Analysis]
2 Kanda T, Sasaki R, Masuzaki R, Takahashi H, Fujisawa M, Matsumoto N, Okamoto H, Moriyama M. Additive Effects of Zinc Chloride on the Suppression of Hepatitis A Virus Replication by Interferon in Human Hepatoma Huh7 Cells. In Vivo 2020;34:3301-8. [PMID: 33144437 DOI: 10.21873/invivo.12168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Thébault A, Roque-afonso A, Kooh P, Cadavez V, Gonzales-barron U, Pavio N. Risk factors for sporadic hepatitis A infection: A systematic review and meta-analysis. Microbial Risk Analysis 2021;17:100155. [DOI: 10.1016/j.mran.2020.100155] [Reference Citation Analysis]